{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:21:03Z","timestamp":1762507263148,"version":"3.37.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s13721-017-0162-9","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T11:49:44Z","timestamp":1513597784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Systems biology approach deciphering the biochemical signaling pathway and pharmacokinetic study of PI3K\/mTOR\/p53-Mdm2 module involved in neoplastic transformation"],"prefix":"10.1007","volume":"7","author":[{"given":"Devender","family":"Arora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3461-6420","authenticated-orcid":false,"given":"Ajeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,18]]},"reference":[{"issue":"3","key":"162_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc2329","volume":"8","author":"AR Anderson","year":"2008","unstructured":"Anderson AR, Quaranta V (2008) Integrative mathematical oncology. Nat Rev Cancer 8(3):227\u2013234","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"162_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ptr.1605","volume":"19","author":"R Arora","year":"2005","unstructured":"Arora R, Gupta D, Chawla R, Sagar R, Sharma A, Kumar R, Prasad J, Singh S, Samanta N, Sharma RK (2005) Radioprotection by plant products: present status and future prospects. Phytother Res 19(1):1\u201322","journal-title":"Phytother Res"},{"key":"162_CR3","doi-asserted-by":"crossref","unstructured":"Arora D, Singh V, Singh A (2016) Modeling and simulation analysis of Salmonella typhimurium inside human epithelial cells: host-pathogen relationship analysis by system biology. In: Bioinformatics and systems biology (BSB), IEEE, pp 1\u20134","DOI":"10.1109\/BSB.2016.7552121"},{"key":"162_CR4","first-page":"1","volume":"26","author":"D Arora","year":"2017","unstructured":"Arora D, Chaudhary R, Singh A (2017a) System biology approach to identify potential receptor for targeting cancer and biomolecular interaction studies of indole [2, 1-a] isoquinoline derivative as anticancerous drug candidate against it. Interdiscip Sci Sciences 26:1","journal-title":"Interdiscip Sci Sciences"},{"issue":"3","key":"162_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1504\/IJBRA.2017.085854","volume":"13","author":"D Arora","year":"2017","unstructured":"Arora D, Jyoti K, Singh A (2017b) Understanding the role of Salmonella pathogenic island 1 (SPI-I) and host-pathogen interaction for typhoid using system biology approach. Int J Bioinform Res Appl 13(3):187\u2013199","journal-title":"Int J Bioinform Res Appl"},{"issue":"5","key":"162_CR6","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1073\/pnas.0510857103","volume":"103","author":"AG Bader","year":"2006","unstructured":"Bader AG, Kang S, Vogt PK (2006) Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc Natl Acad Sci 103(5):1475\u20131479","journal-title":"Proc Natl Acad Sci"},{"issue":"34","key":"162_CR7","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1038\/onc.2012.567","volume":"32","author":"EM Beauchamp","year":"2013","unstructured":"Beauchamp EM, Platanias LC (2013) The evolution of the TOR pathway and its role in cancer. Oncogene 32(34):3923\u20133932","journal-title":"Oncogene"},{"issue":"2","key":"162_CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430340203","volume":"34","author":"MR Boyd","year":"1995","unstructured":"Boyd MR, Paull KD (1995) Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res 34(2):91\u2013109","journal-title":"Drug Dev Res"},{"issue":"1","key":"162_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0092-8674(00)81693-1","volume":"100","author":"R Brent","year":"2000","unstructured":"Brent R (2000) Genomic biology. Cell 100(1):169\u2013183","journal-title":"Cell"},{"issue":"2","key":"162_CR10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrc991","volume":"3","author":"P Ch\u00e8ne","year":"2003","unstructured":"Ch\u00e8ne P (2003) Inhibiting the p53\u2013MDM2 interaction: an important target for cancer therapy. Nat Rev Cancer 3(2):102\u2013109","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"162_CR11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nrd2999","volume":"8","author":"LK Chico","year":"2009","unstructured":"Chico LK, Van Eldik LJ, Watterson DM (2009) Targeting protein kinases in central nervous system disorders. Nat Rev Drug Discov 8(11):892\u2013909","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"162_CR12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0006-2952(01)00785-7","volume":"62","author":"PA Clarke","year":"2001","unstructured":"Clarke PA, te Poele R, Wooster R, Workman P (2001) Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem Pharmacol 62(10):1311\u20131336","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"162_CR13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrd773","volume":"1","author":"P Cohen","year":"2002","unstructured":"Cohen P (2002) Protein kinases\u2014the major drug targets of the twenty-first century? Nat Rev Drug Discov 1(4):309\u2013315","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"162_CR14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1021\/cb300610s","volume":"8","author":"P Cohen","year":"2012","unstructured":"Cohen P, Alessi DR (2012) Kinase drug discovery\u2013what\u2019s next in the field? ACS Chem Biol 8(1):96\u2013104","journal-title":"ACS Chem Biol"},{"key":"162_CR15","unstructured":"Csizmadia P (1999) September. MarvinSketch and MarvinView: molecule applets for the World Wide Web. In: Proceedings of ECSOC-3, the third international electronic conference on synthetic organic chemistry, September 1\u010530, pp 367\u2013369"},{"issue":"1","key":"162_CR16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1752-0509-2-39","volume":"2","author":"A Dr\u00e4ger","year":"2008","unstructured":"Dr\u00e4ger A, Hassis N, Supper J, Schr\u00f6der A, Zell A (2008) SBMLsqueezer: a cell designer plug-into generate kinetic rate equations for biochemical networks. BMC Syst Biol 2(1):39","journal-title":"BMC Syst Biol"},{"issue":"5","key":"162_CR17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"S Forli","year":"2016","unstructured":"Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ (2016) Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc 11(5):905\u2013919","journal-title":"Nat Protoc"},{"issue":"56","key":"162_CR18","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","volume":"22","author":"JS Fridman","year":"2003","unstructured":"Fridman JS, Lowe SW (2003) Control of apoptosis by p53. Oncogene 22(56):9030\u20139040","journal-title":"Oncogene"},{"issue":"5","key":"162_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1478-5382(03)02370-9","volume":"1","author":"A Funahashi","year":"2003","unstructured":"Funahashi A, Morohashi M, Kitano H, Tanimura N (2003) Cell Designer: a process diagram editor for gene-regulatory and biochemical networks. Biosilico 1(5):159\u2013162","journal-title":"Biosilico"},{"key":"162_CR20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/978-1-59745-531-2_21","volume-title":"Introduction to systems biology","author":"A Funahashi","year":"2007","unstructured":"Funahashi A, Morohashi M, Matsuoka Y, Jouraku A, Kitano H (2007) cell designer: a graphical biological network editor and workbench interfacing simulator. In: Choi S (ed) Introduction to systems biology. Humana Press, New York, pp 422\u2013434"},{"issue":"8","key":"162_CR21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1109\/JPROC.2008.925458","volume":"96","author":"A Funahashi","year":"2008","unstructured":"Funahashi A, Matsuoka Y, Jouraku A, Morohashi M, Kikuchi N, Kitano H (2008) Cell Designer 3.5: a versatile modeling tool for biochemical networks. Proc IEEE 96(8):1254\u20131265","journal-title":"Proc IEEE"},{"issue":"1","key":"162_CR22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-\u03b2 as major players and therapeutic targets. J Cell Mol Med 10(1):76\u201399","journal-title":"J Cell Mol Med"},{"key":"162_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(08)60785-X","volume":"77","author":"P Hainaut","year":"1999","unstructured":"Hainaut P, Hollstein M (1999) p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 77:81\u2013137","journal-title":"Adv Cancer Res"},{"issue":"5","key":"162_CR24","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"5506","key":"162_CR25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.291.5506.1001","volume":"291","author":"JL Hartman","year":"2001","unstructured":"Hartman JL, Garvik B, Hartwell L (2001) Principles for the buffering of genetic variation. Science 291(5506):1001\u20131004","journal-title":"Science"},{"issue":"1","key":"162_CR26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1021\/bp070084g","volume":"24","author":"BS Hendriks","year":"2008","unstructured":"Hendriks BS, Hua F, Chabot JR (2008) Analysis of mechanistic pathway models in drug discovery: p38 pathway. Biotechnol Prog 24(1):96\u2013109","journal-title":"Biotechnol Prog"},{"issue":"24","key":"162_CR27","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/bioinformatics\/btl485","volume":"22","author":"S Hoops","year":"2006","unstructured":"Hoops S, Sahle S, Gauges R, Lee C, Pahle J, Simus N, Singhal M, Xu L, Mendes P, Kummer U (2006) COPASI\u2014a complex pathway simulator. Bioinformatics 22(24):3067\u20133074","journal-title":"Bioinformatics"},{"issue":"4","key":"162_CR28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/bioinformatics\/btg015","volume":"19","author":"M Hucka","year":"2003","unstructured":"Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D (2003) Cornish-Bowden A, Cuellar AA. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19(4):524\u2013531","journal-title":"Bioinformatics"},{"issue":"1\u20132","key":"162_CR29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11010-011-1070-4","volume":"360","author":"TE Hutchinson","year":"2012","unstructured":"Hutchinson TE, Zhang J, Xia SL, Kuchibhotla S, Block ER, Patel JM (2012) Enhanced phosphorylation of caveolar PKC-\u03b1 limits peptide internalization in lung endothelial cells. Mol Cell Biochem 360(1\u20132):309\u2013320","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"162_CR30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1534-5807(01)00086-7","volume":"1","author":"RH Insall","year":"2001","unstructured":"Insall RH, Weiner OD (2001) PIP3, PIP2, and cell movement\u2014similar messages, different meanings? Dev Cell 1(6):743\u2013747","journal-title":"Dev Cell"},{"issue":"1","key":"162_CR31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncponc0403","volume":"3","author":"RK Jain","year":"2006","unstructured":"Jain RK, Duda DG, Clark JW, Loeffler JS (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 3(1):24\u201340","journal-title":"Nat Clin Pract Oncol"},{"issue":"9","key":"162_CR32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrd2871","volume":"8","author":"PA J\u00e4nne","year":"2009","unstructured":"J\u00e4nne PA, Gray N, Settleman J (2009) Factors underlying sensitivity of cancers to small-molecule kinase inhibitors. Nat Rev Drug Discov 8(9):709\u2013723","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"162_CR33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/bjd.13706","volume":"173","author":"P Jayaraj","year":"2015","unstructured":"Jayaraj P, Sen S, Sharma A, Chosdol K, Kashyap S, Rai A, Pushker N, Bajaj M (2015) Eyelid sebaceous carcinoma: a novel mutation in lymphoid enhancer-binding factor-1. Br J Dermatol 173(3):811\u2013814","journal-title":"Br J Dermatol"},{"issue":"1","key":"162_CR34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27\u201330","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"162_CR35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/cam4.62","volume":"2","author":"E Koutsogiannouli","year":"2013","unstructured":"Koutsogiannouli E, Papavassiliou AG, Papanikolaou NA (2013) Complexity in cancer biology: is systems biology the answer? Cancer Med 2(2):164\u2013177","journal-title":"Cancer Med"},{"issue":"1","key":"162_CR36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgp261","volume":"31","author":"PK Kreeger","year":"2010","unstructured":"Kreeger PK, Lauffenburger DA (2010) Cancer systems biology: a network modeling perspective. Carcinogenesis 31(1):2\u20138","journal-title":"Carcinogenesis"},{"issue":"53","key":"162_CR37","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1038\/sj.onc.1203015","volume":"18","author":"ND Lakin","year":"1999","unstructured":"Lakin ND, Jackson SP (1999) Regulation of p53 in response to DNA damage. Oncogene 18(53):7644\u20137655","journal-title":"Oncogene"},{"issue":"20","key":"162_CR38","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122(20):3589\u20133594","journal-title":"J Cell Sci"},{"key":"162_CR39","first-page":"237","volume":"4","author":"NE Lewis","year":"2013","unstructured":"Lewis NE, Abdel-Haleem AM (2013) The evolution of genome-scale models of cancer metabolism. Front Physiol 4:237","journal-title":"Front Physiol"},{"issue":"9","key":"162_CR40","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/pro.2121","volume":"21","author":"MC Lin","year":"2012","unstructured":"Lin MC, Lin GZ, Hwang CI, Jian SY, Lin J, Shen YF, Lin G (2012) Synthesis and evaluation of a new series of tri-, di-, and mono-N-alkylcarbamylphloroglucinols as conformationally constrained inhibitors of cholesterol esterase. Protein Sci 21(9):1344\u20131357","journal-title":"Protein Sci"},{"issue":"12","key":"162_CR41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nrd1600","volume":"3","author":"I Melnikova","year":"2004","unstructured":"Melnikova I, Golden J (2004) Targeting protein kinases. Nat Rev Drug Discov 3(12):993\u2013994","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"162_CR42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-1119(99)00487-4","volume":"242","author":"J Momand","year":"2000","unstructured":"Momand J, Wu HH, Dasgupta G (2000) MDM2\u2014master regulator of the p53 tumor suppressor protein. Gene 242(1):15\u201329","journal-title":"Gene"},{"issue":"1","key":"162_CR43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0092-8674(00)81774-2","volume":"95","author":"C Prives","year":"1998","unstructured":"Prives C (1998) Signaling to p53: breaking the MDM2\u2013p53 circuit. Cell 95(1):5\u20138","journal-title":"Cell"},{"issue":"11","key":"162_CR44","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","volume":"13","author":"E Rozengurt","year":"2014","unstructured":"Rozengurt E, Soares HP, Sinnet-Smith J (2014) Suppression of feedback loops mediated by PI3K\/mTOR induces multiple over activation of compensatory pathways: an unintended consequence leading to drug resistance. Mol Cancer Ther 13(11):2477\u20132488","journal-title":"Mol Cancer Ther"},{"issue":"18","key":"162_CR45","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.12.18.2831","volume":"12","author":"K Sakaguchi","year":"1998","unstructured":"Sakaguchi K, Herrera JE, Saito SI, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E (1998) DNA damage activates p53 through a phosphorylation\u2013acetylation cascade. Genes Dev 12(18):2831\u20132841","journal-title":"Genes Dev"},{"issue":"20 Suppl","key":"162_CR46","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1158\/1078-0432.CCR-13-2107","volume":"19","author":"CL Sawyers","year":"2013","unstructured":"Sawyers CL, Abate-Shen C, Anderson KC, Barker A, Baselga J, Berger NA, Foti M, Jemal A, Lawrence TS, Li CI, Mardis ER (2013) AACR cancer progress report 2013. Clin Cancer Res 19(20 Suppl):S1\u2013S98","journal-title":"Clin Cancer Res"},{"issue":"17","key":"162_CR47","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1158\/1078-0432.CCR-07-5136","volume":"14","author":"S Shangary","year":"2008","unstructured":"Shangary S, Wang S (2008) Targeting the MDM2-p53 interaction for cancer therapy. Clin Cancer Res 14(17):5318\u20135324","journal-title":"Clin Cancer Res"},{"issue":"3\u20134","key":"162_CR48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1947601912455199","volume":"3","author":"D Shi","year":"2012","unstructured":"Shi D, Gu W (2012) Dual roles of MDM2 in the regulation of p53 ubiquitination dependent and ubiquitination independent mechanisms of MDM2 repression of p53 activity. Genes Cancer 3(3\u20134):240\u2013248","journal-title":"Genes Cancer"},{"issue":"6","key":"162_CR49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/ceo.12517","volume":"43","author":"L Singh","year":"2015","unstructured":"Singh L, Pushker N, Sen S, Singh MK, Chauhan FA, Kashyap S (2015) Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters. Clin Exp Ophthalmol 43(6):550\u2013557","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"162_CR50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"56","key":"162_CR51","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1038\/sj.onc.1204086","volume":"19","author":"J Turkson","year":"2000","unstructured":"Turkson J, Jove R (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19(56):6613","journal-title":"Oncogene"},{"issue":"6810","key":"162_CR52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein B, Lane D, Levine AJ (2000a) Surfing the p53 network. Nature 408(6810):307\u2013310","journal-title":"Nature"},{"issue":"6810","key":"162_CR53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","volume":"408","author":"B Vogelstein","year":"2000","unstructured":"Vogelstein B, Lane D, Levine AJ (2000b) Surfing the p53 network. Nature 408(6810):307\u2013310","journal-title":"Nature"},{"issue":"3","key":"162_CR54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1574362409666140206221931","volume":"8","author":"V Manstein von","year":"2013","unstructured":"von Manstein V, Min Yang C, Richter D, Delis N, Vafaizadeh V, Groner B (2013) Resistance of cancer cells to targeted therapies through the activation of compensating signaling loops. Curr Signal Transduct Ther 8(3):193\u2013202","journal-title":"Curr Signal Transduct Ther"},{"issue":"8","key":"162_CR55","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","volume":"2","author":"KH Vousden","year":"2002","unstructured":"Vousden KH, Lu X (2002) Live or let die: the cell\u2019s response to p53. Nat Rev Cancer 2(8):594\u2013604","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"162_CR56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","volume":"13","author":"M Wade","year":"2013","unstructured":"Wade M, Li YC, Wahl GM (2013) MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 13(2):83\u201396","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"162_CR57","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/sj.onc.1207411","volume":"23","author":"Y Yang","year":"2004","unstructured":"Yang Y, Li CC, Weissman AM (2004) Regulating the p53 system through ubiquitination. Oncogene 23(11):2096\u20132106","journal-title":"Oncogene"},{"issue":"8","key":"162_CR58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc3309","volume":"12","author":"Y Yarden","year":"2012","unstructured":"Yarden Y, Pines G (2012) The ERBB network: at last, cancer therapy meets systems biology. Nat Rev Cancer 12(8):553\u2013563","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"162_CR59","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nbt1338","volume":"25","author":"MA Y\u0131ld\u0131r\u0131m","year":"2007","unstructured":"Y\u0131ld\u0131r\u0131m MA, Goh KI, Cusick ME, Barab\u00e1si AL, Vidal M (2007) Drug\u2014target network. Nat Biotechnol 25(10):1119\u20131126","journal-title":"Nat Biotechnol"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13721-017-0162-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-017-0162-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-017-0162-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T21:04:25Z","timestamp":1719695065000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13721-017-0162-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,18]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1007\/s13721-017-0162-9","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"type":"print","value":"2192-6662"},{"type":"electronic","value":"2192-6670"}],"subject":[],"published":{"date-parts":[[2017,12,18]]},"article-number":"2"}}